Pfizer Archives - The Federal

.td-main-page-wrap
{
    padding-top: 0px;
}

.category-padding-remove .td-post-category
{
    padding-left:0px;
}

@media(min-width: 1019px) {
.td_block_24 .td-column-2 .td_module_19 .td-module-image {
left: auto;
right: 0;

}
.td_block_24 .td-column-2 .td_module_19 .td-item-details {
margin-left: 0;
margin-right: 294px;
}
}

.title-headings-cm
{
    
}

.img-left-elections  a
{
        background-position: left center!important;
}

.remove-title .td-block-title-wrap
{
    display: none;
}

.navigation-center .td-next-prev-wrap 
{
        text-align: center;
}

.spotlight-federal
{
   /* height: 72px; */
}

.features-single-post-federal .td-image-container
{
    
    width: 627px;
}

.features-story-federal .td_block_single_image
{
       height: 245px;
}

.features-story-federal .td_module_flex_1
{
       height: 288px;
}

.states-list-type .td_module_flex_3 .entry-title::before
{ 
     color: #FF9900;
    content: "\2022";
    font-size: 40px;
    padding: 0px;
    padding-right: 8px;
    position: relative;
    top: 8px;
    margin-left: -20px;
  
}

.opinion-img-border .entry-thumb
{
    border: 2px solid #FF9900;
}

.election-heading .td-block-title 
{
                                                
  background-image: url('https://thefederal.com/file/2019/02/Group-339.png');
  
      background-repeat: no-repeat;
      padding-left: 53px;
      height: 38px;
          padding-top: 5px;
}

.elections-row-height
{
    
}

.remove-link .td-pulldown-category
{
    display:none;
}

.inner-page-infinite .td-post-author-name
{
    display:none;
}

.inner-page-infinite .td-module-comments
{
    display:none;
}

.inner-page-infinite .td-read-more

{
    display:none;
        counter-reset: esum;
}

.order-list-federal div.td_module_flex_1{

position: relative;
  counter-increment: esum;
  padding: 10px;
    
    
}

.order-list-federal div.td_module_flex_1:before{
     content: counter(esum);
     background-color: #FF9900;
       padding: 12px;
    color: white;
    font-size: 41px;
  float: left;
    margin-top: 13px;
    margin-right: 5px;
}

.features-single-post-federal .td_module_flex_1
{
    height: 100%;
}

.leadstory-image
{
    height: 100%!important;
}

.home-vid{
    
}

.featured-template-c-single-post .entry-title 
{
    display: none;
}
.faultlines .entry-title.td-module-title, .disableanchortag .td-module-title {
    display: none;
}
.liveicon .live-tag-federal .td-post-category{
    display: block;
    background-color: red !important;
    padding-top: 5px;
    color: #fff;
    text-transform: capitalize !important;
    margin-left:10px;
    }
.liveicon .td-post-category{
    display:none;
}
.liveicon .live-tag-federal{
    width:33%;
}

.eighthcolum .td-module-meta-info{
    margin-top: 75px;
    
}
.eighthcolum .td-block-title-wrap{
    position: absolute;
}
.eighthcolum .td-image-container{
    width: 30%;
    /*margin-top: -77px;*/
    
    
}
@media screen and (max-width: 767px) {
    .eighthcolum .td-image-container{
    width: 100% !important;
    margin-top: 0;
    order: 1!important;
    }
    .eighthcolum .td-pulldown-size{
        margin: 30px 0 0 25px !important;
        
    }
}
.eighthcolum .td-module-meta-info{
padding: 0 0 0 50px;
    
}
.eighthcolum .td-pulldown-size{
color: #fff;
background: url(https://thefederal.com/file/2019/03/eye.png)no-repeat 0px;
padding-left: 28px;
font-size: 18px;
font-weight: 400;
margin: 30px 0 0 48px;
}
.repluck .td-element-style {
    background-color: #ccc !important;
}
.eighthcolum .entry-title a{
position:absolute;
}
.eighthcolum h1.entry-title {
    margin-bottom:50px !important;
}
.eighthcolum h3.entry-title{
    margin-bottom:50px !important;
}

@media screen and(max-width:767px){
    .eighthcolum .entry-title a{
position:relative !important;
}
.eighthcolum h3.entry-title{
    margin-bottom:20px !important;
}
    
}

Pfizer

Centre may turn ‘Purchase Head’, procure COVID vaccines for all states

Coming soon: A vaccine from pharma major Wockhardt

Why are COVID vaccine manufacturers so keen on indemnity?

Pfizer says its vaccine effective on COVID mutant, suitable for 12+

Pfizer vaccine: Firm seeks indemnity from any claims in India

Mixing COVID vaccines can give you mild side effects, but not harmful: Study

US FDA authorises Pfizer’s vaccine for use in children aged 12 to 15

India needs more than patent waivers to deliver more COVID vaccines

COVID-vaccine’s import licence to be cleared in 3 days after approval